PROTHENA CORP PLC's ticker is PRTA and the CUSIP is G72800108. A total of 190 filers reported holding PROTHENA CORP PLC in Q3 2023. The put-call ratio across all filers is 1.91 and the average weighting 0.3%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EcoR1 Capital, LLC | 11,584,280 | $558,941,510 | 18.85% |
Finepoint Capital LP | 349,300 | $16,853,725 | 8.39% |
Palo Alto Investors LP | 1,657,458 | $79,972,349 | 7.57% |
Birchview Capital, LP | 169,574 | $8,181,946 | 6.96% |
First Light Asset Management, LLC | 1,494,039 | $72,087,382 | 6.85% |
DCF Advisers, LLC | 82,950 | $4,002,338 | 2.18% |
Prosight Management, LP | 126,202 | $6,089,247 | 1.93% |
PFM Health Sciences, LP | 836,571 | $40,364,551 | 1.90% |
SECTORAL ASSET MANAGEMENT INC | 172,407 | $8,318,638 | 1.62% |
Boxer Capital, LLC | 625,000 | $30,156,250 | 1.60% |
Affinity Asset Advisors, LLC | 79,214 | $3,822,076 | 1.08% |
Maple Rock Capital Partners | 234,584 | $11,318,678 | 1.00% |
Rock Springs Capital Management LP | 614,298 | $29,639,879 | 0.79% |
Avidity Partners Management LP | 382,305 | $18,446,216 | 0.74% |
Granahan Investment Management | 348,065 | $16,794,136 | 0.60% |
Deep Track Capital, LP | 250,000 | $12,062,500 | 0.47% |
Pier Capital, LLC | 57,456 | $2,772,252 | 0.45% |
Frazier Life Sciences Management, L.P. | 127,900 | $6,171,175 | 0.41% |
SILVERARC CAPITAL MANAGEMENT, LLC | 26,629 | $1,284,849 | 0.39% |
Eventide Asset Management | 445,155 | $21,478,729 | 0.39% |
External links
This page lists PROTHENA CORP PLC's shareholders in Q3 2023. To view PROTHENA CORP PLC's shareholder history, click here.